Dr. Sunderlal & Swarn Bahl Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Dr. Sunderlal & Swarn Bahl Foundation
The Company is engaged in the Non-Profit Organizations Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Bahl, Neel Bahl, and Rajesh Bahl serve as directors at the Company.
- CIN/LLPIN
U85300MH2021NPL361454
- Company No.
361454
- Company Classification
Private Not For Profit Company
- Incorporation Date
02 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr. Sunderlal & Swarn Bahl Foundation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Bahl  | Director | 02-Jun-2021 | Current |
Neel Bahl  | Director | 02-Jun-2021 | Current |
| Rajesh Bahl | Director | 02-Jun-2021 | Current |
Financial Performance of Dr. Sunderlal & Swarn Bahl Foundation.
Enhance accessibility to Dr. Sunderlal & Swarn Bahl Foundation's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr. Sunderlal & Swarn Bahl Foundation?
Unlock access to Dr. Sunderlal & Swarn Bahl Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gee Cee Holdings Limited Liability Partn ErshipActive 14 years 8 monthsRajiv Bahl and Rajesh Bahl are mutual person
- Geochem Laboratories (Indore) LlpActive 7 years 6 months
Rajiv Bahl and Rajesh Bahl are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Sunderlal & Swarn Bahl Foundation?
Dr. Sunderlal & Swarn Bahl Foundation has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Sunderlal & Swarn Bahl Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Sunderlal & Swarn Bahl Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
